PDF-ikonPrintikonTell a friend

Björn Pasternak, MD, PhD

Björn Pasternak
Researcher
Statens Serum Institut
5 Artillerivej , 206/222
DK-2300 Copenhagen S
Denmark
+45 3268 3268
Phone:
+4532688150
E-mail:

Responsibilities

Research in pharmacoepidemiology.

Research area

-Medication safety in pregnancy.

-Cardiovascular safety of medications.

-Comparative effectiveness of common medications.

-Vaccine safety and effectiveness.

Selected publications

Pregnancy:

Mølgaard-Nielsen D, Pasternak B, Hviid A Use of Oral Fluconazole during Pregnancy and the Risk of Birth Defects. N Engl J Med.2013; 369, 830-839

Pasternak B, Svanström H, Hviid A Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes. N Engl J Med.2013; 368, 814-823

Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg H, Melbye M, Hviid A Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ.2012; 344, e2794

Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg H, Melbye M, Hviid A Risk of adverse fetal outcomes following administration of a pandemic influenza A (H1N1) vaccine during pregnancy. JAMA.2012; 308, 165-174

Pasternak B, Hviid A Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA.2010; 304, 859-866

Pasternak B, Hviid A Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med.2010; 363, 2114-2123

Cardiovascular:

Svanström H, Pasternak B, Hviid A Use of azithromycin and cardiovascular death. N Engl J Med.2013; 368, 1704-1712

Svanström H, Pasternak B, Hviid A Use of varenicline and the risk of serious cardiovascular events: Nationwide cohort study. BMJ.2012; 345, e7176

Svanström H, Pasternak B, Hviid A Association of treatment with losartan vs candesartan and mortality among patients with heart failure. JAMA.2012; 307, 1506-1512

Publikationer

Link til Pub Med